Robot model
Ottava
Table-integrated robotically-assisted surgical system for soft-tissue procedures.
- Manufacturer
- Johnson and Johnson MedTech
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
Overview
Table-integrated robotically-assisted surgical system for soft-tissue procedures. Robotic arms are built into the operating table, reducing the system footprint by 30-50 percent compared to conventional boom- or cart-mounted systems. FDA De Novo marketing authorization granted July 22, 2026 for upper-abdominal procedures.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- None on file
- Sources on file
- 1 source, view all
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Key facts
Manufacturer
Type
Maturity
Data & sources
News coverage
1
1 source backing this record.View all →
Pricing
No verified price is on record for Ottava. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Ottava on the deployment map
Where Ottava is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 23, 2026
Added to the verified registry
- Incident recordedJul 22, 2026
FDA grants De Novo marketing authorization to J&J Ottava surgical robot
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting Ottava (1)
- FDA grants De Novo marketing authorization to J&J Ottava surgical robot2026-07-22 · Regulatory action
Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Sources (1)
Common questions
- What is Ottava?
- Table-integrated robotically-assisted surgical system for soft-tissue procedures. Robotic arms are built into the operating table, reducing the system footprint by 30-50 percent compared to conventional boom- or cart-mounted systems. FDA De Novo marketing authorization granted July 22, 2026 for upper-abdominal procedures.
- How much does Ottava cost?
- Ottava's price is not publicly disclosed. DEPLOY has no verified price on record for Ottava from Johnson and Johnson MedTech. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is Ottava actually deployed in the real world?
- Ottava is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.
- Who makes Ottava?
- Ottava is made by Johnson and Johnson MedTech, based in New Brunswick, NJ, USA, founded in 1886.
- Can you buy Ottava?
- Ottava is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- What are alternatives to Ottava?
- On the DEPLOY registry, comparable surgical robots to Ottava include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does Ottava compare to Toumai?
- Ottava and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. Ottava has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- What is Ottava's maturity stage?
- Ottava is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Where is Ottava deployed?
- No verified deployments of Ottava are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- Is Ottava safe?
- Ottava has 1 active incident on record in the DEPLOY registry. 1 incident on record. Most recent: Jul 2026. Retracted incidents are excluded from this count.
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-07-23
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-07-23
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- secondary-established-publication
- Established publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Ottava.Recent coverage
Ottava in third-party press
In the press
Recent coverage mentioning Ottava from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /models/ottava.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/aa3172dd-364a-4296-873b-25ad26747519
- Revision history: /models/ottava/history
- Data documentation: /data
- Query this programmatically: Deploy MCP